Joel Sendek
Overview
Joel Sendek received $1M in total compensation, including $237K in salary, at Spero Therapeutics in 2017.
Source: SEC filing on April 27, 2018.
Related executives
We found six more executives who work or worked at Spero Therapeutics.
Ankit Mahadevia
Spero Therapeutics
Chief Executive Officer
Satyavrat Shukla
Spero Therapeutics
Chief Executive Officer
Tamara Joseph
Spero Therapeutics
Chief Legal Officer
Cristina Larkin
Spero Therapeutics
Chief Operating Officer
Christina Larkin
Spero Therapeutics
Chief Operating Officer
David Melnick
Spero Therapeutics